Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals, Small, vol.25, issue.16, pp.1794-1805, 2010. ,
DOI : 10.1002/smll.201000538
Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model [CrossRef] [PubMed] 3. Wilczewska, A Nanoparticles as drug delivery systems Mesoporous silica nanoparticles in medicine?Recent advances Porous silicon nanoparticles for nanomedicine: Preparation and biomedical applications, Biodegradable luminescent porous silicon nanoparticles for in vivo applications, pp.4131-4144, 2009. ,
Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy, CrossRef] [PubMed] 8. Gobin,CrossRef] [PubMed] 9. Sailor, M.J.; Wu, E.C. Photoluminescence-Based Sensing With Porous Silicon Films, Microparticles, and Nanoparticles, pp.25-38, 1929. ,
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles, Nature Communications, vol.14, pp.2326-2332, 2013. ,
DOI : 10.1021/bc025600x
Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumors, Angewandte Chemie, vol.18, issue.48, pp.11627-11631, 2011. ,
DOI : 10.1016/j.suronc.2009.02.002
URL : https://hal.archives-ouvertes.fr/hal-00646023
Biological Impacts of Nanoparticles, Journal of the American Chemical Society, vol.133, issue.8, pp.2525-2534, 2011. ,
DOI : 10.1021/ja107583h
Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT, Int. J. Pharm, vol.2012, issue.423, pp.509-515 ,
Surface Functionalization of Silica Nanoparticles Supports Colloidal Stability in Physiological Media and Facilitates Internalization in Cells, Langmuir, vol.28, issue.20, pp.7598-7613, 2012. ,
DOI : 10.1021/la204913t
Mannose-functionalized porous silica-coated magnetic nanoparticles for two-photon imaging or PDT of cancer cells, Journal of Nanoparticle Research, vol.361, issue.1, pp.1-17, 2013. ,
DOI : 10.1016/j.jcis.2011.05.038
URL : https://hal.archives-ouvertes.fr/hal-00841213
Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy, Chemical Communications, vol.18, issue.39, pp.2013-4202 ,
DOI : 10.1002/adma.200502420
URL : https://hal.archives-ouvertes.fr/hal-00809285
Mannose-6-Phosphate Receptor: A Target for Theranostics of Prostate Cancer, Angewandte Chemie, vol.432, issue.20, pp.6050-6054, 2015. ,
DOI : 10.1016/j.ijpharm.2012.04.056
Polymeric protective agents for nanoparticles in drug delivery and targeting, Int. J. Pharm, vol.2, pp.419-429, 2016. ,
Drug Carrier for Photodynamic Cancer Therapy, International Journal of Molecular Sciences, vol.5, issue.9, pp.22094-22136 ,
DOI : 10.1016/j.jaad.2003.10.471
URL : http://www.mdpi.com/1422-0067/16/9/22094/pdf
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery, Chemistry - A European Journal, vol.1, issue.40, pp.13850-13865, 2015. ,
DOI : 10.1002/adhm.201200067
URL : https://hal.archives-ouvertes.fr/hal-01334973
Multifunctional silica nanoparticles for pancreatic cancer specific drug delivery and bioimaging, J. Chem. Appl. Biochem, vol.2, pp.110-116, 2015. ,
Porous Silicon Nanoparticle Photosensitizers for Singlet Oxygen and Their Phototoxicity against Cancer Cells, ACS Nano, vol.5, issue.5, pp.3651-3659, 2011. ,
DOI : 10.1021/nn1035262
Two-Photon Excitation of Porphyrin-Functionalized Porous Silicon Nanoparticles for Photodynamic Therapy, Advanced Materials, vol.119, issue.45, pp.7643-7648, 2014. ,
DOI : 10.1021/ja971209o
URL : https://hal.archives-ouvertes.fr/hal-01096066
Understanding biophysicochemical interactions at the nano???bio interface, Nature Materials, vol.20, issue.7, pp.543-557, 2009. ,
DOI : 10.1289/ehp.6000
Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified Nanoparticles, Molecular Pharmaceutics, vol.10, issue.9, pp.3525-3530, 2013. ,
DOI : 10.1021/mp400216r
Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomed, vol.1, pp.297-315, 2006. ,
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives, Angewandte Chemie International Edition, vol.61, issue.36, pp.6288-6308, 2010. ,
DOI : 10.3109/10731199009117287
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells, Nanoscale, vol.2, issue.8, pp.3198-3207, 2011. ,
DOI : 10.1088/1748-6041/2/4/003
Porous silicon nanoparticles for cancer photothermotherapy, Nanoscale Research Letters, vol.6, issue.1, 2011. ,
DOI : 10.1021/nn900904h
URL : http://doi.org/10.1186/1556-276x-6-321
Functionalization of Mesoporous Silica Nanoparticles for Targeting, Biocompatibility, Combined Cancer Therapies and Theragnosis, Journal of Nanoscience and Nanotechnology, vol.13, issue.4 ,
DOI : 10.1166/jnn.2013.7363
Morère, A. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy, Chem. Commun, pp.1475-1477, 2009. ,
Small sized mesoporous silica nanoparticles functionalized with mannose for retinoblastoma cell imaging, RSC Advances, vol.7, issue.50, pp.37171-37179, 2014. ,
DOI : 10.1021/nn304045q
URL : https://hal.archives-ouvertes.fr/hal-01068017
Mesoporous silicon nanoparticles for targeted two-photon theranostics of prostate cancer, Journal of Materials Chemistry B, vol.9, issue.1, pp.3639-3642, 2016. ,
DOI : 10.1039/c3cc38837a
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery, Advanced Materials, vol.103, issue.12, pp.1504-1534 ,
DOI : 10.1093/jnci/djr400
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses, Biomaterials, vol.31, issue.6, pp.1085-1092, 2010. ,
DOI : 10.1016/j.biomaterials.2009.10.046
In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation, Small, vol.117, issue.2, pp.271-280, 2011. ,
DOI : 10.1016/j.micromeso.2008.08.004
Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions, physica status solidi (a), vol.197, issue.2, pp.331-335, 2003. ,
DOI : 10.1002/pssa.200306519
Interactions between solid surfaces with adsorbed polyelectrolytes of opposite charge, Current Opinion in Colloid & Interface Science, vol.13, issue.6, pp.429-437, 2008. ,
DOI : 10.1016/j.cocis.2008.02.006
Intracellular pH-Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics, Angewandte Chemie, vol.266, issue.44, pp.8390-8395, 2010. ,
DOI : 10.1002/ange.201002639
Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake, ACS Nano, vol.9, issue.7, pp.6996-7008, 2015. ,
DOI : 10.1021/acsnano.5b01326
Irreversible Binding of Transferrin to Polystyrene Nanoparticles: Soft and Hard Corona, ACS Nano, vol.6, issue.3, pp.2532-2541, 2012. ,
DOI : 10.1021/nn204951s
Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells, ACS Nano, vol.6, issue.7, pp.5845-5857, 2012. ,
DOI : 10.1021/nn300223w
Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?, Nanoscale, vol.12, issue.135, pp.1658-1668, 2013. ,
DOI : 10.1107/S0909049505012719
URL : https://hal.archives-ouvertes.fr/hal-01426275
???Stealth??? corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids and Surfaces B: Biointerfaces, vol.18, issue.3-4, pp.301-313, 2000. ,
DOI : 10.1016/S0927-7765(99)00156-3
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Advanced Drug Delivery Reviews, vol.61, issue.6, pp.61-428, 2009. ,
DOI : 10.1016/j.addr.2009.03.009
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation, Journal of Biomedical Materials Research Part A, vol.13, pp.1236-1243, 2010. ,
DOI : 10.1016/j.ijrobp.2006.09.011
The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes, Biomaterials, vol.34, issue.10, pp.2565-2575, 2013. ,
DOI : 10.1016/j.biomaterials.2012.12.043
Control of the in vivo Biodistribution of Hybrid Nanoparticles with Different Poly(ethylene glycol) Coatings, Small, vol.6, issue.22, pp.2565-2575, 2009. ,
DOI : 10.1002/smll.200900563
Targeted Liposomal Drug Delivery to Monocytes and Macrophages, Journal of Drug Delivery, vol.5, issue.1, 2011. ,
DOI : 10.1016/j.jconrel.2008.08.017
URL : https://doi.org/10.1155/2011/727241
PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics, Nano Letters, vol.12, issue.10, pp.5304-5310, 2012. ,
DOI : 10.1021/nl302638g